Messages in brief

News

New account number

messages in brief | 25/07/2013

Please note the new account number of the Federal Office for Safety in Health Care (BASG) / AGES Medizinmarktaufsicht:

BAWAG P.S.K. AG IBAN: AT59…

New account number Read more
News

Ergot derivatives (various preparations)

Safety warnings | messages in brief | 28/06/2013
Ergot derivatives (various preparations)
Ergot derivatives (various preparations) Read more
News

PANGEA VI: Worldwide Internet Raid

messages in brief | 27/06/2013

More than 100 countries participated in this year's week of action against the illegal sale of medicines on the Internet.

In total, more than nine…

PANGEA VI: Worldwide Internet Raid Read more
News

Federal Office for Safety in Health Care

messages in brief | 26/06/2013
Please note that, with effect from 1 July 2013, product information texts should be submitted via the PHAROS eService "Marketing Authorisation &…
Federal Office for Safety in Health Care Read more
News

Importation of active ingredients for medicinal products for human use: new regulation

messages in brief | 26/06/2013

As of 02.07.2013, new regulations apply to the import of active ingredients for medicinal products for human use into the European Union. As of this…

Importation of active ingredients for medicinal products for human use: new regulation Read more
News

Risk for medication errors Methotrexate

Safety warnings | messages in brief | 18/04/2013
Methotrexate (various preparations)
Risk for medication errors Methotrexate Read more
News

Highly Variable Drugs

messages in brief | 14/02/2013

If there are major differences in the measurement of pharmacokinetic parameters, such as the AUC or Cmax, after repeated administration of the…

Highly Variable Drugs Read more
News

Oral contraceptives

Safety warnings | messages in brief | 29/01/2013

Combined oral contraceptives (COCs) are divided into four generations depending on the type of progestogen they contain.

The European Medicines…

Oral contraceptives Read more
News

Local scientific literature and suspected side effects

messages in brief | 20/11/2012

The "Guideline on good pharmacovigilance practices", Module VI obliges marketing authorization holders, among other things, to monitor the local…

Local scientific literature and suspected side effects Read more
Email

Further inquiry note